Weight Loss Drug
US$ 23.76
semaglutide diabetes trial A 72-week compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Efficacy and tolerability by semaglutide
Description
36 Months The full effects of treatment usually manifest within this period
Wegovy is taken once a week, with a gradual dose increase over 16-20 weeks to minimise side effects
[DOI] [PubMed] [Google Scholar] 144.Veluthakal R., Esparza D., Hoolachan J.M., Balakrishnan R., Ahn M., Oh E., Jayasena C.S., Thurmond D.C
However, some side effects need medical attention
Ozempic and Rybelsus are primarily prescribed for managing type 2 diabetes, although they often lead to weight loss as a secondary effect
